Ministry of Health & Prevention Signs Agreement with Neopharma Drug Factory to Increase Emergency Medicine Inventory
The Ministry of Health and Prevention (MOHAP) recently signed an agreement with Neopharma Factory to provide some medical stocks made use of for emergency situation circumstances, including 103 types of pharmaceutical products, medications for emergency instances and various other medications to even more boost the health safety of the nation following the instructions under the Council of Ministers No. 39 of 2015.
H.E. Dr. Amin Hussein Al Amiri, Assistant Undersecretary of Public Health Policy and Licensing of the Ministry of Health & Prevention, accompanied by Dr. Abdul Karim Abdullah Al Zarouni, Director of the Division of Emergency Situation, Dilemma and Disaster Operations, authorized the contract on behalf of the Ministry while Suresh Kumar Nandirajo, Chief Operating Officer of Neopharma, signed for the company.
Stock of medicine covering one year
Dr. Amin Al Amiri kept in mind that MOHAP continually reinforces its medicine supply by signing arrangements with medicine producers adhering to the choice of the Council of Ministers No. 39 of 2015. The agreement with Neopharma is part of our initiatives to boost health and clinical safety, and allow us to quickly reply to emergency situations with the purchase of strategic clinical stocks for the Ministry's shops. This covers our demands for one year, including stocks for 3 months that are easily offered in the form of completed goods while the staying quantity will be in the form of basic materials that will be utilized in the medicines' manufacturing process.
Dr. Amin emphasized that the Ministry works towards constructing quality and safety and security systems for treatment, health and medicine based on international standards and envisions to advertise a healthy culture by providing thorough and innovative health services which the Ministry implements a regulative and auditor role in the health sector complying with an advanced and incorporated health legal system. He included that the assistance and partnership with pharmaceutical producers such as NeoPharma contributes to the promotion and sustainability of healthcare infrastructure.
Pharmaceutical products included in the agreement
Dr. Abdul-Karim Al-Zarouni discussed that the contract likewise sets a device for recycling supplies and constantly provides fresh items to customers while keeping the total supply quantity called for. The ministry is accountable for storing and keeping medical supplies according to the global storage space and recycling standards.
The list of medicines consisted of in the agreement comprise a total of 103 drug categories, including 27 for the treatment of respiratory, 22 for illness of the ear nose and throat, 13 kinds of medications for the treatment of breathing diseases, 9 products for the therapy of heart diseases, nine for chronic illness, 8 for intestinal diseases, 6 for the urinary tract, gynecology and obstetrics, four for blood illness and lack of nutrition, 4 for bone diseases and one medication for illness of the nervous system.
Suresh Kumar said the company is committed to offering the pharmaceutical manufacturing in the UAE, and commented: "We are honored to work with the Ministry of Health and Avoidance to supply vital clinical supplies that profit the community throughout times of crisis, and to enable effective methods to take care of healthcare prices, rise access to crucial medicines and add to the conditioning of the pharmacoeconomy in the country.
